Portnoy Law Firm Announces Class Action on Behalf of Dow, Inc. Investors

(NYSE:DOW), LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Dow, Inc., (“Dow” or the “Company”) (NYSE: DOW) investors off a class action on behalf of investors that bought securities between January 30, 2025 and July 23, 2025, inclusive (the “Class Period”). Dow investors have until October 28, 2025 to file […]

InventHelp Inventor Develops Improved Caulking Gun (TLS-939)

“I thought there could be a better way to increase visibility when working with a caulking gun in poorly lit areas,” said an inventor, from Kansas City, Mo., “so I invented THE CAULK GUNS ASSISTANT. My design eliminates the need to struggle with a traditional lighting source.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The patent-pending invention provides an improved design

Class Action Alert: Levi & Korsinsky Reminds Fortinet, Inc. (FTNT) Investors of November 21, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Fortinet, Inc. (NASDAQ:FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=174177&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Portnoy Law Firm Announces Class Action on Behalf of Dow, Inc. Investors

Portnoy Law Firm Announces Class Action on Behalf of Dow, Inc. Investors GlobeNewswire October 27, 2025 LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Dow, Inc., (“Dow” or the “Company”) (NYSE: DOW) investors off a class action on behalf of investors that bought securities between January 30, 2025 and July

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Quanex Building Products Corporation of Class Action Lawsuit And Upcoming Deadlines – NX

NEW YORK CITY, NY / ACCESS Newswire / October 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE:NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

SOUR PUNCH(R) CANDY BRAND PUCKERS UP FOR LIMITED RELEASE OF ALL PICKLE STRAWS

It's 2025, and pickle flavor fans are still having their moment. From chips, to cotton candy – even mayonnaise – shoppers are seeing a delightful amount of dill on the shelf. https://mma.prnewswire.com/media/2806183/American_Licorice_Company__Sour_Punch_All_Pickle_Straws.jpg Pickle Roulette SuccessAs pickle flavored CPG products were starting to make their mark in the marketplace, the Sour Punch brand decided to play

Fly-E Group, Inc. (FLYE) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 10, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=174176&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease

The Alzheimer Society of Ontario calls for immediate system investments to support access to the newly approved dementia treatment TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) — The Alzheimer Society of Ontario applauds the approval of Lecanemab by Health Canada. This is a historic step forward in the treatment of Alzheimer's disease, and the Alzheimer Society

Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease

Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer's Disease GlobeNewswire October 27, 2025 The Alzheimer Society of Ontario calls for immediate system investments to support access to the newly approved dementia treatment TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) — The Alzheimer Society of Ontario applauds the approval of Lecanemab by

Scroll to Top